{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T06:54:16Z","timestamp":1773903256023,"version":"3.50.1"},"reference-count":21,"publisher":"Informa UK Limited","issue":"2","license":[{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1080\/13696998.2019.1696349","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T09:12:22Z","timestamp":1574327542000},"page":"132-138","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":10,"title":["Hospitalization and emergency department utilization in patients with advanced melanoma receiving pembrolizumab versus ipilimumab plus nivolumab in US academic centers"],"prefix":"10.1080","volume":"23","author":[{"given":"Richard W.","family":"Joseph","sequence":"first","affiliation":[{"name":"Department of Oncology (Medical), Mayo Clinic, Jacksonville, FL, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia C.","family":"Shillington","sequence":"additional","affiliation":[{"name":"EPI-Q, Inc, Oak Brook, IL, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes, and Policy, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cynthia P.","family":"Macahilig","sequence":"additional","affiliation":[{"name":"Medical Data Analytics (MDA), Parsippany, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott J.","family":"Diede","sequence":"additional","affiliation":[{"name":"Merck & Co, North Wales, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaidehi","family":"Dave","sequence":"additional","affiliation":[{"name":"Medical Data Analytics (MDA), Parsippany, NJ, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Harshaw","sequence":"additional","affiliation":[{"name":"EPI-Q, Inc, Oak Brook, IL, USA;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Scherrer","sequence":"additional","affiliation":[{"name":"Merck & Co, North Wales, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank Xiaoqing","family":"Liu","sequence":"additional","affiliation":[{"name":"Merck & Co, North Wales, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2019,12,9]]},"reference":[{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2010-0190"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.12.2205"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.12.0253"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa8172"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30388-2"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910836"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-018-2241-x"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2016.1184155"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-015-0757-y"},{"issue":"4","key":"CIT0013","first-page":"203","volume":"9","author":"Bilir SP","year":"2016","journal-title":"Am Health Drug Benefits"},{"issue":"7","key":"CIT0014","first-page":"334","volume":"11","author":"Ghate SR","year":"2018","journal-title":"Am Health Drug Benefits"},{"key":"CIT0015","unstructured":"Vouk K, Benter U, Amonkar MM. Cost and economic burden of adverse events associated with metastatic melanoma treatments in five countries."},{"issue":"2","key":"CIT0016","first-page":"158","volume":"21","author":"Arondekar B","year":"2015","journal-title":"J Manag Care Spec Pharm"},{"key":"CIT0017","unstructured":"\u201cWhat Is The Oncology Care Model, And Why Is The Evaluation Important? \u201cHealth Affairs Blog, February 14, 2019."},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.2217\/imt-2018-0150"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1002\/0471249688"},{"key":"CIT0021","author":"Wang Lx Quach HT","year":"2019","journal-title":"Cancer"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.4236\/jct.2015.610091"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1062356"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2019.18442"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13696998.2019.1696349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T02:17:04Z","timestamp":1578363424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13696998.2019.1696349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,9]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"alternative-id":["10.1080\/13696998.2019.1696349"],"URL":"https:\/\/doi.org\/10.1080\/13696998.2019.1696349","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ijme20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-10-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}